Viewing nowRosuva Tablet 10 Milligrams (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

MFDS item code 201007499 · Approved 2010.12.16 · Insurance code 663604300
Improvement of dyslipidemia, inhibition of the progression of atherosclerosis, and reduction of cardiovascular disease risk
This medication is primarily used as an adjunct to diet in patients with primary hypercholesterolemia and heterozygous familial hypercholesterolemia, and combined hyperlipidemia. It effectively lowers LDL-cholesterol and total cholesterol levels within the target range, delaying the progression of atherosclerosis. It is particularly prescribed for pediatric patients aged 10 to 17 years who have elevated LDL-cholesterol levels that cannot be controlled by diet alone. It is also used as an adjunct in the treatment of patients with primary dysbetalipoproteinemia. In middle-aged and older men and women at risk for cardiovascular disease, it helps to reduce the risk of stroke, myocardial infarction, and vascular revascularization, thereby maintaining cardiovascular health. Therefore, it is used for various forms of hyperlipidemia and risk reduction for cardiovascular diseases.
1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of the day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 3. Elderly : No dosage adjustment is necessary. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race : Since systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (10 to 17 years of age): The usual dose range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goals for each patient. The dose should be adjusted at intervals of 4 weeks or more. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, patients with an allergy to any components of this drug, unexplained elevation of liver enzymes, patients with muscle diseases, those with severe renal impairment, and women who are pregnant or breastfeeding should not take this medication. Additionally, high-dose use of this medication is prohibited in patients at high risk of muscle-related diseases. Such patients include those with moderate to severe renal impairment, hypothyroidism, a family history of muscle disease, and alcohol dependence. This medication contains lactose; therefore, it should not be administered to patients with lactose intolerance or related genetic disorders. When administering this drug, caution is necessary for those with excessive alcohol consumption or a history of liver disease, and repeated liver function tests are recommended before and during treatment. If symptoms of muscle pain or weakness occur, inform a physician immediately and check for muscle damage through blood tests. Particularly, if muscle enzyme levels rise significantly, the medication should be discontinued. It is safe to stop taking this medication during acute severe illness or post-surgical conditions. This medication may interact with other drugs; therefore, it is essential to inform about any other medications being taken, especially when combined with those that may increase the risk of muscle toxicity. Women who may become pregnant should use appropriate contraception and should not take this medication during pregnancy. There is no specific antidote for overdose, so treatment should be symptomatic, and liver function and muscle enzyme tests are needed. This medication does not significantly affect driving or operating machinery, but dizziness may occur; caution is advised. Finally, if symptoms such as skin rash, itching, severe muscle pain, or jaundice occur during treatment, consult medical personnel immediately.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, fatigue, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distension, syncope, widespread pain
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture; therefore, it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve the drug's efficacy and safety over time.
Pink round film-coated tablets
For domestic use: 28 tablets (14 tablets/PTP X 2), for export: 56 tablets (14 tablets/PTP X 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.